One Health: Insights from The Lancet One Health Commission, Dr. John Amuasi and Prof. Andrea Sylvia Winkler
Résumé (en anglais)
One Health is an interdisciplinary field of knowledge and practice that recognizes the fundamentally interdependent nature of health among humans, animals, and the environment that we share. One Health offers, as The Lancet One Health Commission will demonstrate, a systemic and sustainable response to some of the most complex and pressing global health challenges of the contemporary era. From the health threats posed by climate change, declining biodiversity, and food insecurity to those of emerging and endemic infectious diseases, antimicrobial resistance, and non-communicable diseases, the ambition of The Lancet One Health Commission is to galvanize the integrated approach to health at human-animal-environment interface on which our shared future depends. Chaired by Dr. John Amuasi and Prof. Andrea S. Winkler, The Lancet One Health Commission comprises the expertise of approximately 30 internationally renowned and multidisciplinary commissioners and scientific advisors from around the world.
Biographie des invités
Dr. John Amuasi and Prof. Andrea Sylvia Winkler
Co-Chairs of The Lancet One Health Commission
Dr. John Amuasi lectures at the Kwame Nkrumah University of Science and Technology (KNUST), where he is based at the Global Health Department of the School of Public Health and is head of the Department of Community Health at the School of Medicine and Dentistry. Dr. Amuasi is also Group Leader of the Global Health and Infectious Diseases Research Group at the Kumasi Center for Collaborative Research in Tropical Medicine (KCCR), which hosts the Secretariat of the African Research Network for Neglected Tropical Diseases (ARNTD) of which he is the Executive Director. Dr. Amuasi trained as a physician at the KNUST School of Medical Sciences, and later graduated from the University of Minnesota School of Public Health, USA, with post-graduate degrees terminating in a PhD in Health Research and Policy. He also served as head of the R&D Unit at the 1,200-bed Komfo Anokye teaching Hospital in Kumasi, Ghana for 3 years from 2007-2010. Dr. Amuasi has consulted for several international organizations and is passionate about research that focuses on improving health systems, services and outcomes, including policy analyses using both primary and secondary data in low and middle-income countries.
His research currently involves field epidemiologic studies on malaria, snakebite and other neglected tropical diseases. Dr. Amuasi also co-chairs the Lancet One Health Commission and is at the fore-front of global efforts towards addressing emerging and re-emerging infectious diseases. He serves as an Executive Committee member of the African Coalition for Epidemic Research, Response and Training (ALERRT). Through ALERRT at KCCR, Dr. Amuasi is coordinating the setup of research on the clinical characterization of COVID-19 in Africa and is the PI for a number of studies on COVID-19 in Ghana, including a phase III clinical trial.
Prof. Andrea Sylvia Winkler, MD, Dr. med., PhD, is a specialist neurologist, a senior researcher and the co-director of the Center for Global Health at the Technical University of Munich. She is also the deputy director of the Centre for Global Health at the University of Oslo, where she holds a full professorship in Global Health. Prof. Winkler has 18 years of experience with both clinical work and research in countries of sub-Saharan Africa. Her special interest lies with poverty-related neglected diseases of the infectious as well as non-infectious nature, global neurology/mental health and global digital health. She had/has leading roles in various large-scale multidisciplinary health consortia in sub-Saharan Africa funded by the German Research Foundation, the Bill and Melinda Gates Foundation, the Norwegian Research Council and the Germany Ministry of Education and Research, among others and co-chairs the Lancet One Health Commission (together with Dr. John Amuasi, KCCR, Ghana) with offices in Germany, Ghana and Norway.
Dre Hélène Carabin
Directrice du Groupe de Recherche en Épidémiologie des Zoonoses et Santé Publique (GREZOSP), responsable de l'axe Une seule santé du monde pour le Centre de Recherche en Santé Publique (CReSP)
Dre Hélène Carabin est co-directrice du réseau global Une seule santé sur la gouvernance des maladies infectieuses et l'antibiorésistance, et commissaire sur le Lancet One Health Commission. Elle est aussi Professeure titulaire au département de Pathologie et Microbiologie de la Faculté de Médecine Vétérinaire et au Département de Médecine Sociale et Préventive à l’École de Santé Publique de l’Université de Montréal. Son programme de recherche est axé sur l’utilisation de méthodes épidémiologiques et biostatistiques avancées pour mieux comprendre les facteurs de risque et le fardeau des maladies infectieuses et évaluer les programmes de contrôle, avec une emphase sur les maladies des populations les plus démunies et celles affectant à la fois les animaux et les humains.